Starting from 1st of June 2017, Dr. Maria Bastian is appointed as Chief Science Officer at AGILeBiotics.
Starting from 1st of June 2017, Dr. Maria Bastian is appointed as Chief Science Officer at AGILeBiotics.
AGILeBiotics B.V. is a pharmaceutical company focusing on the development of novel antibiotics for the treatment of multi-drug resistant infections